US preorders COVID-19 vaccine and antibody therapy

Novavax will earn $1.6 billion for its vaccine and Regeneron $450 million for its antibodies
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
More News: Chemistry | COVID-19 | Vaccines